5/6
07:30 am
sage
Sage Therapeutics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Sage Therapeutics (SAGE)
Low
Report
Sage Therapeutics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Sage Therapeutics (SAGE)
5/4
09:00 pm
sage
Sage Therapeutics, Inc. Investigated by Shareholder Rights Advocates – Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - SAGE
Low
Report
Sage Therapeutics, Inc. Investigated by Shareholder Rights Advocates – Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - SAGE
5/4
09:00 pm
sage
SAGE ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Sage Therapeutics, Inc.
Low
Report
SAGE ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Sage Therapeutics, Inc.
5/4
07:02 pm
sage
SAGE ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Sage Therapeutics, Inc.
Low
Report
SAGE ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Sage Therapeutics, Inc.
5/4
12:00 pm
sage
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
5/2
04:45 pm
sage
ATTENTION Sage Therapeutics, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
Medium
Report
ATTENTION Sage Therapeutics, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
5/2
04:45 pm
sage
Sage Therapeutics, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - SAGE
Medium
Report
Sage Therapeutics, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - SAGE
5/2
03:51 pm
sage
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
5/2
10:00 am
sage
An Investigation Has Commenced on Behalf of Sage Therapeutics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your SAGE Losses.
Low
Report
An Investigation Has Commenced on Behalf of Sage Therapeutics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your SAGE Losses.
5/1
11:40 am
sage
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at JPMorgan Chase & Co. from $29.00 to $28.00. They now have an "overweight" rating on the stock.
Medium
Report
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at JPMorgan Chase & Co. from $29.00 to $28.00. They now have an "overweight" rating on the stock.
4/30
01:10 pm
sage
Sage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Sage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
4/28
09:00 am
sage
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
Medium
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
4/28
08:56 am
sage
Earnings Update: Sage Therapeutics, Inc. (NASDAQ:SAGE) Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance]
Medium
Report
Earnings Update: Sage Therapeutics, Inc. (NASDAQ:SAGE) Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance]
4/27
02:04 am
sage
Sage Therapeutics, Inc. (NASDAQ: SAGE) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
Sage Therapeutics, Inc. (NASDAQ: SAGE) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
4/26
02:36 pm
sage
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at HC Wainwright from $28.00 to $25.00. They now have a "neutral" rating on the stock.
Low
Report
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at HC Wainwright from $28.00 to $25.00. They now have a "neutral" rating on the stock.
4/26
01:39 pm
sage
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $28.00 to $19.00. They now have a "neutral" rating on the stock.
Low
Report
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $28.00 to $19.00. They now have a "neutral" rating on the stock.
4/26
01:08 pm
sage
Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates [Yahoo! Finance]
Low
Report
Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates [Yahoo! Finance]
4/26
12:00 pm
sage
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
4/26
11:59 am
sage
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at Truist Financial Co. from $22.00 to $18.00. They now have a "hold" rating on the stock.
Low
Report
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at Truist Financial Co. from $22.00 to $18.00. They now have a "hold" rating on the stock.
4/26
11:59 am
sage
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at Royal Bank of Canada from $26.00 to $15.00. They now have a "sector perform" rating on the stock.
Low
Report
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at Royal Bank of Canada from $26.00 to $15.00. They now have a "sector perform" rating on the stock.
4/26
11:15 am
sage
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at Mizuho from $20.00 to $18.00. They now have a "neutral" rating on the stock.
Low
Report
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at Mizuho from $20.00 to $18.00. They now have a "neutral" rating on the stock.
4/26
09:08 am
sage
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $21.00 to $17.00. They now have a "hold" rating on the stock.
Low
Report
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $21.00 to $17.00. They now have a "hold" rating on the stock.
4/26
07:54 am
sage
Sage Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Low
Report
Sage Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
4/25
05:15 pm
sage
INVESTIGATION ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sage Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
Medium
Report
INVESTIGATION ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sage Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
4/25
08:01 am
sage
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Low
Report
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.